HCA news

HCA Healthcare intends to use proceeds for general corporate purposes including debt repayment. The offering is led by Mizuho Securities USA LLC.

HCA Healthcare reported third quarter 2026 revenues of $19.85 billion and adjusted earnings per share of $7.22 for the period, demonstrating operational resilience despite challenges from federal policy changes and a shift in payer mix, including increased uninsured volumes. The healthcare company r…

HCA Healthcare reported Q2 2026 revenues of $20.23 billion, up 8.7%, despite an unfavorable payer mix shift of $400 million, boosting investor confidence in the healthcare sector's resilience.

HCA Healthcare reported preliminary Q2 2026 results with revenues and earnings exceeding prior year figures. The company revised its 2026 guidance downward due to an unfavorable payer mix shift and declining surgical volume.

Hyundai ABS Funding LLC completed issuance and sale of Class A and Class B/C notes on June 17, 2026, backed by retail installment sale receivables. This ABS transaction provides liquidity for Hyundai Capital America's auto financing portfolio.

Hyundai ABS Funding LLC filed an 8-K regarding the issuance of notes by Hyundai Auto Receivables Trust 2026-B on June 9, 2026. This asset-backed securitization transaction pools auto receivables to create tradable securities for capital markets.

Hyundai ABS Funding and Hyundai Capital America completed an underwriting agreement for $2.187 billion in asset-backed notes across seven classes on June 9, 2026. The offering reflects continued securitization activity in the auto finance market through Hyundai's structured finance program.